Adjunct Faculty
Adjunct Faculty are scientists or others who are employed outside of the school but have a specific, mutually beneficial role to Yale School of Medicine department programs.
Adjunct rank detailsNeera Dahl, MD, PhD
Professor AdjunctDownloadHi-Res Photo
About
Copy Link
Titles
Professor Adjunct
Director, Nephrology Clinical Trials Program, Nephrology
Positions outside Yale
Medical Director, Outpatient Dialysis, Nephrology, DaVita New Haven
Biography
Dr. Dahl has expertise in diagnosis and management of inherited (or genetically based) kidney disease. Her main focus has been ADPKD and other cystic kidney diseases which mimic ADPKD. She is the medical director of the New Haven DaVita unit providing in center hemodialysis, home hemodialysis and peritoneal dialysis. She is the Director of the Nephrology Clinical Trials program overseeing studies in ADPKD, diabetes and hypertension. In collaboration with Dr. Dinesh Singh she runs the Yale Kidney Stone Clinic.
Last Updated on April 07, 2025.
Appointments
Nephrology
Professor AdjunctPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Beth Israel Deaconess Medical Center (2002)
- Resident
- Beth Israel Deaconess Medical Center (1999)
- Intern
- BIDMC, Harvard Medical School (1997)
- PhD
- Tufts University (1996)
- MD
- Tufts University School of Medicine (1996)
- BA
- Johns Hopkins University (1987)
- Postdoctoral, PhD
- Tufts University School of Medicine and Sackler School of Biomedical Science
Research
Copy Link
Overview
In collaboration with Dr. Tinika Montgomery (nephrology), Drs. Dinesh Singh, Piruz Motamedinia, and Tim Tran (urology) we have created a Kidney Stone Registry to track important aspects of kidney stone management.
In the inherited kidney disease space I am most interested in those aspects of clinical research which improve care for ADPKD patients.
Medical Research Interests
Kidney Diseases; Nephrology
ORCID
0000-0001-5809-9961
Research at a Glance
Yale Co-Authors
Frequent collaborators of Neera Dahl's published research.
Publications Timeline
A big-picture view of Neera Dahl's research output by year.
Research Interests
Research topics Neera Dahl is interested in exploring.
Stefan Somlo, MD
Whitney Besse, MD
Cassius Iyad Ochoa Chaar, MD, MPH, MS, RPVI
Gilbert Moeckel, MD, PhD, FASN
Abinet Aklilu, MD, MPH
Margaret Bia, MD
97Publications
1,374Citations
Kidney Diseases
Nephrology
Publications
2025
Deep Learning-Based Instance-Level Segmentation of Kidney and Liver Cysts in CT Images of Patients Affected by Polycystic Kidney Disease.
Gregory A, Khalifa M, Im J, Ramanathan S, Elbarougy D, Cruz C, Yang H, Denic A, Rule A, Chebib F, Dahl N, Hogan M, Harris P, Torres V, Erickson B, Potretzke T, Kline T. Deep Learning-Based Instance-Level Segmentation of Kidney and Liver Cysts in CT Images of Patients Affected by Polycystic Kidney Disease. Kidney360 2025 PMID: 40811034, DOI: 10.34067/kid.0000000924.Peer-Reviewed Original ResearchCitationsConceptsAutosomal dominant polycystic kidney diseaseLiver cystsCT scanPolycystic kidney diseaseAbdominal CTCT imagesAdvanced biomarkersKidney diseaseCT scans of patientsTotal cyst numberContrast-enhanced CTCT images of patientsNon-contrast CTDominant polycystic kidney diseasePrediction of disease progressionScans of patientsImages of patientsADPKD patientsInter-readerLiver volumeTotal kidneyDisease progressionImage-based biomarkersPatientsImaging modalitiesAutosomal dominant polycystic kidney disease without apparent family history: A single-center experience.
Samuels M, Maarouf O, Zeng W, Hamrahian M, Dahl N, Zhang J. Autosomal dominant polycystic kidney disease without apparent family history: A single-center experience. Clinical Nephrology 2025, 104: 144-151. PMID: 40329829, DOI: 10.5414/cn111677.Peer-Reviewed Original ResearchConceptsAutosomal dominant polycystic kidney diseaseDisease-causing variantsDominant polycystic kidney diseaseFamily historyPolycystic kidney diseaseAutosomal dominant polycystic kidney disease phenotypeKidney diseaseHistory of autosomal dominant polycystic kidney diseaseFamily history of autosomal dominant polycystic kidney diseaseSingle-center experienceApparent family historyThomas Jefferson University HospitalGenetic test resultsADPKD patientsPKD patientsKidney functionGenetic diagnosisGenetic testingUniversity HospitalAccurate diagnosisPatientsKidney failureClinical diagnosisDisease accountPracticing nephrologistsStructured Application of Genetic Testing in a Pediatric Kidney Clinic.
Salcedo-Giraldo J, Wink K, Dadzie N, Freiman A, Pyle T, Gordish-Dressman H, Moxey-Mims M, Dahl N, Guay-Woodford L, Gulati A. Structured Application of Genetic Testing in a Pediatric Kidney Clinic. Journal Of The American Society Of Nephrology 2025 PMID: 40728892, DOI: 10.1681/asn.0000000816.Peer-Reviewed Original ResearchConceptsGenetic test resultsInherited kidney diseaseGenetic testingGenetic dataApplication of genetic testingClinical care planningPositive outcome measuresClinical genetic testingDiagnosis-based treatmentPathogenic/likely pathogenic variantsAssociated with positive outcomesCare planningGenetics expertiseKidney clinicGenetic data of patientsManagement of kidney diseaseMultidisciplinary careKidney diseaseGenetic workflowPediatric settingOutcome measuresPositive clinical outcomesOutpatient programDisease managementGenetic variantsClinical Practice Guidelines for Genetic Testing in ADPKD
Dahl N, Garimella P, Chebib F. Clinical Practice Guidelines for Genetic Testing in ADPKD. Kidney News 2025, 17: 12-13. DOI: 10.62716/kn.000812025.Peer-Reviewed Original ResearchAltmetricCardiovascular Complications in ADPKD
Ebrahimi N, Caliskan Y, Garimella P, Carriazo S, Chebib F, Bateni G, Dahl N, Rastogi A, Abdipour A, Norouzi S. Cardiovascular Complications in ADPKD. Kidney International Reports 2025, 10: 2953-2966. PMID: 40980664, PMCID: PMC12446925, DOI: 10.1016/j.ekir.2025.06.054.Peer-Reviewed Original ResearchAltmetricConceptsAutosomal dominant polycystic kidney diseaseRenin-angiotensin-aldosterone systemLeft ventricular hypertrophyChronic kidney diseaseCardiovascular manifestationsKidney diseasePericardial effusionCardiovascular complicationsEarly detectionCardiovascular diseaseChronic kidney disease progressionHereditary kidney diseaseDominant polycystic kidney diseaseImpaired endothelial functionRenin-angiotensin-aldosteroneBurden of comorbiditiesHigh-risk populationPolycystic kidney diseaseVascular structural changesCause of mortalityPatterns of age distributionValvular involvementDiastolic dysfunctionValvular abnormalitiesExtrarenal manifestationsResolution of acute kidney injury following intensive dialysis for oxalate nephropathy.
Roth J, Buglioni A, Dahl N. Resolution of acute kidney injury following intensive dialysis for oxalate nephropathy. Clinical Nephrology 2025 PMID: 40454527, DOI: 10.5414/cn111664.Peer-Reviewed Original ResearchConceptsAcute kidney injuryOxalate nephropathyKidney injuryStage III acute kidney injuryIII acute kidney injuryResolution of acute kidney injuryUrinary excretion of oxalateIncreased urinary excretion of oxalateAbsorption of dietary oxalateDeposition of calcium oxalate crystalsIncreased absorption of dietary oxalateSerum oxalate levelsExcretion of oxalateIncreased urinary excretionChronic kidney diseaseRenal outcomesRenal recoveryEnteric hyperoxaluriaBariatric proceduresFat malabsorptionIntensive dialysisSecondary hyperoxaluriaRenal parenchymaBiliopancreatic diversionBariatric patientsResponse to the Letter to the Editor Entitled “Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes”
Dahl N, Torres V. Response to the Letter to the Editor Entitled “Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes”. Kidney International Reports 2025, 10: 2880. PMID: 40814628, PMCID: PMC12348087, DOI: 10.1016/j.ekir.2025.05.040.Peer-Reviewed Original ResearchAutosomal Dominant Polycystic Kidney Disease
Chebib F, Hanna C, Harris P, Torres V, Dahl N. Autosomal Dominant Polycystic Kidney Disease. JAMA 2025, 333: 1708-1719. PMID: 40126492, DOI: 10.1001/jama.2025.0310.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdultAneurysm, RupturedAntidiuretic Hormone Receptor AntagonistsDisease ProgressionGlomerular Filtration RateHumansHypertensionIntracranial AneurysmKidneyPolycystic Kidney, Autosomal DominantRenal Insufficiency, ChronicRenal Replacement TherapySeverity of Illness IndexTolvaptanTreatment OutcomeTRPP Cation ChannelsConceptsAutosomal dominant polycystic kidney diseaseMayo imaging classificationRate of eGFR declineKidney replacement therapyEGFR declineDevelopment of kidney cystsKidney diseaseKidney failureReplacement therapyMm HgVasopressin type 2 receptor antagonist tolvaptanProgression to kidney replacement therapyAnnual rate of eGFR declineAdequate hydrationIntracranial aneurysmsManagement of Autosomal Dominant Polycystic Kidney DiseaseWeight managementProgression to kidney failureDietary sodium restrictionFirst-line treatmentKidney cystsSeverity of kidney diseaseTotal kidney volumeDominant polycystic kidney diseaseDe novo diseaseCharacterizing the ADPKD-IFT140 Phenotypic Signature With Deep Learning and Advanced Imaging Biomarkers
Ghanem A, Debeh F, Borghol A, Zagorec N, Tapia A, Smith B, Paul S, Basit A, AlKhatib B, Nader N, Antoun M, Gregory A, Yang H, Schauer R, Dahl N, Hanna C, Torres V, Kline T, Harris P, Gall E, Chebib F. Characterizing the ADPKD-IFT140 Phenotypic Signature With Deep Learning and Advanced Imaging Biomarkers. Kidney International Reports 2025, 10: 2690-2707. PMID: 40814641, PMCID: PMC12348249, DOI: 10.1016/j.ekir.2025.04.062.Peer-Reviewed Original ResearchAltmetricConceptsArea under the curveHeight-adjusted total kidney volumeAutosomal dominant polycystic kidney diseaseEstimated glomerular filtrationDisease-causing variantsDevelopment cohortAdvanced imaging biomarkersTotal kidney volumeDominant polycystic kidney diseaseRetrospective cohort studyPolycystic kidney diseaseClinical presentationCyst volumeKidney volumeCyst diameterCystic indexDiverse clinical settingsLiver cystsCohort studyExternal cohortKidney diseaseLarge cystsInternational cohortGlomerular filtrationPatientsIntracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Practical Approach to Screening and Management
Borghol A, Alkhatib B, Zayat R, Ravikumar N, Munairdjy Debeh F, Ghanem A, Mina J, Mao M, Dahl N, Hickson L, Aslam N, Torres V, Brown R, Tawk R, Chebib F. Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Practical Approach to Screening and Management. Mayo Clinic Proceedings 2025, 100: 1030-1050. PMID: 40319406, DOI: 10.1016/j.mayocp.2025.02.003.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAutosomal dominant polycystic kidney diseaseDominant polycystic kidney diseasePolycystic kidney diseaseIntracranial aneurysmsSubarachnoid hemorrhageFamily history of intracranial aneurysmsProgressive kidney function declineKidney diseaseSymptoms related to mass effectRisk factorsBrain magnetic resonance angiographyHistory of intracranial aneurysmsControl of risk factorsFocal neurological deficitsFollow-up careKidney function declineGenetic kidney disordersCharacteristics of intracranial aneurysmsIndicator of subarachnoid hemorrhageMagnetic resonance angiographyNonmodifiable risk factorsPrevent adverse outcomesSaccular intracranial aneurysmsCase-fatality rateThunderclap headache
Academic Achievements & Community Involvement
Copy Link
Activities
activity Scientific Advisory Board
10/01/2018 - PresentAdvisory BoardsAdvisorDetailsPKD Foundationinvolved in grant review and patient outreach projects with the PKD Foundationactivity Medical Review Board
10/01/2015 - PresentAdvisory BoardsBoard MemberDetailsESRD Network of New EnglandHelped determine focus of the ESRD Network projectsactivity National Kidney Foundation, CT Chapter
10/01/2008 - PresentAdvisory BoardsBoard MemberDetailsNational Kidney Foundationactivity American Journal of Kidney Disease
2007 - PresentJournal ServiceRevieweractivity Clinical Journal of the American Society of Nephrology
2007 - PresentJournal ServiceReviewer
Honors
honor ISN Travel Grant
01/01/2013National AwardWorld Congress of NephrologyDetailsUnited Stateshonor Sugarman Postdoctoral Training Grant
01/01/2002, 01/01/2001National AwardNational Kidney FoundationDetailsUnited Stateshonor Training Grant (Renal Fellow)
01/01/2001, 01/01/2000Other AwardHarvard Medical SchoolDetailsUnited Stateshonor Medical Scientist Training Program
01/01/1996, 01/01/1987Regional AwardTufts UniversityDetailsUnited Stateshonor Alpha Omega Alpha
01/01/1996Other AwardTufts University School of MedicineDetailsUnited States
News
Copy Link
News
- February 15, 2024
Hybrid Approach to Arteriovenous Fistula Aneurysm Repair
- July 13, 2023
Support System, Consistency Important For Dialysis Patients During Pandemic (Discoveries & Impact July 2023)
- December 19, 2022
Yale Named Center of Excellence by Polycystic Kidney Disease (PKD) Foundation
- November 12, 2022Source: Web MD
Talking to Your Kids About ADPKD
Get In Touch
Copy Link
Contacts
Email